Get the Stockscreener App
32.10
0.96%
-0.30
Legend Biotech Corp Adr stock is traded at $32.10, with a volume of 617.28K.
It is down -0.96% in the last 24 hours and up +0.09% over the past month.
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
See More
Previous Close:
$32.40
Open:
$32.29
24h Volume:
617.28K
Relative Volume:
0.52
Market Cap:
$5.92B
Revenue:
$797.73M
Net Income/Loss:
$-325.77M
P/E Ratio:
-18.11
EPS:
-1.7725
Net Cash Flow:
$-332.79M
1W Performance:
-0.09%
1M Performance:
+0.09%
6M Performance:
-3.26%
1Y Performance:
-27.66%
1-Day Range:
$31.78
$32.76
1-Week Range:
$31.52
$33.39
52-Week Range:
$27.34
$47.79
Legend Biotech Corp Adr Stock (LEGN) Company Profile
Name
Legend Biotech Corp Adr
Sector
Industry
Phone
-
Address
-
Compare LEGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LEGN
Legend Biotech Corp Adr
|
32.09 | 5.98B | 797.73M | -325.77M | -332.79M | -1.7725 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Legend Biotech Corp Adr Stock (LEGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-08-24 | Initiated | Redburn Atlantic | Buy |
| Jun-17-24 | Initiated | Truist | Buy |
| May-24-24 | Reiterated | H.C. Wainwright | Buy |
| May-23-24 | Initiated | Deutsche Bank | Buy |
| Apr-17-24 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-03-24 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-13-24 | Initiated | Raymond James | Outperform |
| Dec-19-23 | Initiated | Scotiabank | Sector Perform |
| Nov-06-23 | Initiated | Goldman | Buy |
| May-25-23 | Initiated | William Blair | Mkt Perform |
| May-22-23 | Initiated | Daiwa Securities | Buy |
| Mar-29-23 | Initiated | H.C. Wainwright | Buy |
| Mar-24-23 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-22 | Initiated | UBS | Buy |
| Nov-02-22 | Initiated | Evercore ISI | Outperform |
| Nov-01-22 | Initiated | Cowen | Outperform |
| Oct-31-22 | Initiated | Guggenheim | Neutral |
| Jun-17-22 | Initiated | BMO Capital Markets | Outperform |
| Mar-15-22 | Initiated | Barclays | Overweight |
| Jan-31-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-06-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-21-21 | Initiated | Piper Sandler | Overweight |
| May-18-21 | Initiated | BTIG Research | Buy |
| Jul-01-20 | Initiated | JP Morgan | Overweight |
| Jul-01-20 | Initiated | Jefferies | Buy |
| Jun-30-20 | Initiated | Morgan Stanley | Overweight |
View All
Legend Biotech Corp Adr Stock (LEGN) Latest News
iA Global Asset Management Inc. Lowers Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Sumitomo Mitsui Trust Group Inc. Sells 11,157 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
OVERSEA CHINESE BANKING Corp Ltd Invests $723,000 in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Allianz Asset Management GmbH Takes $458,000 Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Nordea Investment Management AB - MarketBeat
TD Asset Management Inc Has $3.67 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth By Investing.com - Investing.com South Africa
H.C. Wainwright lowers Legend Biotech stock price target to $60 on muted growth - Investing.com India
Ameritas Advisory Services LLC Makes New $32,000 Investment in Arbor Realty Trust $ABR - Defense World
Free cash flow per share of Legend Biotech Corp. Sponsored ADR – MUN:9LB - TradingView
Ameritas Advisory Services LLC Acquires Shares of 501 JPMorgan Diversified Return International Equity ETF $JPIN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives $69.25 Average PT from Analysts - Defense World
Vontobel Holding Ltd. Has $368,000 Holdings in Duolingo, Inc. $DUOL - Defense World
Vontobel Holding Ltd. Sells 1,634 Shares of Wynn Resorts, Limited $WYNN - Defense World
Avery Dennison (NYSE:AVY) Receives “Hold (C-)” Rating from Weiss Ratings - Defense World
Pagaya Technologies (NASDAQ:PGY) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Vontobel Holding Ltd. Makes New Investment in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Krystal Biotech, Inc. $KRYS Stock Holdings Boosted by Vontobel Holding Ltd. - Defense World
Vontobel Holding Ltd. Cuts Stock Position in Waters Corporation $WAT - Defense World
Southern Copper Corporation $SCCO Shares Sold by Vontobel Holding Ltd. - Defense World
Vontobel Holding Ltd. Sells 10,000 Shares of Zeta Global Holdings Corp. $ZETA - Defense World
Bennett Associates Wealth Management Has $523,000 Holdings in JPMorgan Chase & Co. $JPM - Defense World
Analysts Set Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Price Target at $69.25 - Defense World
US FDA adds label warning to J&J’s and Legend Biotech’s cancer therapy By Reuters - Investing.com
JPMorgan Chase & Co. Cuts Legend Biotech (NASDAQ:LEGN) Price Target to $76.00 - Defense World
Mirae Asset Global Investments Co. Ltd. Has $530,000 Stock Position in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
US FDA adds boxed warning to J&J, Legend Biotech’s cancer therapy By Reuters - Investing.com
Legend Biotech (NASDAQ:LEGN) Research Coverage Started at Cantor Fitzgerald - Defense World
Legend Biotech Corporation Sponsored ADR $LEGN Shares Sold by Public Employees Retirement System of Ohio - Defense World
GAMMA Investing LLC Has $30,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Matthews International Capital Management LLC Has $45.89 Million Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Voya Investment Management LLC Takes Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Harbor Capital Advisors Inc. Grows Stock Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Rhumbline Advisers Buys 391 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Advisors Asset Management Inc. Has $673,000 Holdings in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - MSN
Alliancebernstein L.P. Purchases 32,101 Shares of Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech stock rating reiterated at Outperform by RBC Capital - Investing.com
Legend Biotech Corporation Sponsored ADR $LEGN Stake Decreased by Cinctive Capital Management LP - MarketBeat
Nomura Holdings Inc. Purchases New Position in Legend Biotech Corporation Sponsored ADR $LEGN - MarketBeat
Legend Biotech at Morgan Stanley Conference: CARVYKTI’s Global Impact - Investing.com
Legend Biotech (NASDAQ:LEGN) Shares Up 5.4%Here's Why - MarketBeat
Legend Biotech Mulling 2nd Listing in HK, Singapore, or London: Wire - AASTOCKS.com
Northern Trust Corp Has $9.73 Million Stake in Legend Biotech Corporation Sponsored ADR $LEGN - Defense World
Rexel (OTCMKTS:RXLSF) Stock Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Cantor Fitzgerald Expects Weaker Earnings for Legend Biotech - MarketBeat
Legend Biotech’s SWOT analysis: carvykti success drives stock potential amid challenges - Investing.com India
Legend Biotech Corp Adr Stock (LEGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):